Novolin Injection, Solution
Product Images NDC 0169-3003

Product Visual Gallery

This gallery contains 40 technical images submitted to the FDA as part of the official labeling for Novolin (NDC 0169-3003). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Novo Nordisk, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structural Formula Of Novolin R (6ede8238 F902 478d 8cee 997855045083 01)

Chemical structure diagram of Human Insulin showing the amino acid sequence of the A-chain and B-chain with disulfide bonds connecting cysteine residues. Amino acids are represented by their three-letter abbreviations, with some shaded and others outlined.*

FDA Label Image

Pull Off Tamper Resistant Cap (Image 01)

Illustration showing hands removing a cap from a small vial, likely demonstrating preparation steps for use of an injectable medication such as Novolin R (Human Insulin) 100 IU/mL solution for subcutaneous injection.*

FDA Label Image

Wipe The Rubber Stopper With An Alcohol Swab (Image 02)

An instructional diagram showing a hand removing or placing the cap on a vial, likely demonstrating preparation for subcutaneous injection. The vial is held upright by one hand, and the other hand is grasping the cap. There is a small label '4B' in the top left corner indicating the step number in the process.*

FDA Label Image

Pull Back The Plunger (Image 03)

An instructional illustration showing a hand holding a syringe with the needle pointed downward and the other hand holding the syringe barrel, with an arrow indicating a downward motion, likely demonstrating how to prepare or expel air from a syringe.*

FDA Label Image

Push The Needle Through The Rubber Stopper Of The Vial (Image 04)

An instructional illustration showing a person drawing liquid from a vial into a syringe, demonstrating proper technique for preparing a subcutaneous injection.*

FDA Label Image

Push The Plunger All The Way In (Image 05)

An instructional illustration showing a person using a syringe to withdraw medication from a vial, depicting the step of inserting the needle into the vial to draw up the solution.*

FDA Label Image

Turn The Vial And Syringe Up And Down (Image 06)

An instructional illustration showing a hand holding a vial inverted above a syringe, with an arrow pointing downward indicating the drawing of liquid from the vial into the syringe. The image visually depicts how to prepare an injection, relevant to injectable products like Novolin R human insulin.*

FDA Label Image

Tap The Syringe Gently (Image 07)

An instructional illustration showing a hand holding a vial upside down to draw a solution into a syringe, indicating the preparation of an injectable medication. The drawing is in black and white with a number '10' in the top left corner.*

FDA Label Image

Press The Plunger Of The Syringe To Inject The Insulin (Image 08)

An instructional illustration showing a hand injecting a solution with a syringe into the subcutaneous tissue of another hand. The image includes an arrow pointing downward to indicate the injection direction.*

FDA Label Image

Exclamation Point. (Image 09)

Novolin R Human Insulin Injection, Solution, 100 IU/mL in a vial. The label includes the brand name Novolin R, the generic name Human Insulin, and indicates it is for subcutaneous use. The vial container is 10 mL. Manufacturer is Novo Nordisk.*

FDA Label Image

Flexpen Ifu 1 (Image 10)

Illustration of the Novolin R FlexPen showing its components including the pen cap, rubber stopper, cartridge with scale, dose pointer selector, and push button. The FlexPen is a subcutaneous injection device for human insulin 100 IU/mL manufactured by Novo Nordisk.*

FDA Label Image

Flexpen Ifu 2 (Image 11)

An instructional illustration showing three types of Novo Nordisk needle assemblies: NovoFine, NovoFine Plus, and NovoTwist. Each type is displayed with labeled components including big outer needle cap, inner needle cap, needle, and protective tab arranged horizontally for comparison.*

FDA Label Image

Pull Off Pen Cap. (Image 12)

An instructional illustration showing two hands holding and preparing an insulin pen for injection. One hand grips the insulin pen, while the other hand pulls a cap or cover away from the pen's tip, indicated by an arrow, demonstrating the removal step before injection.*

FDA Label Image

Flexpen Ifu B (Image 13)

An instructional diagram showing how to use a NovoFine or NovoFine Plus insulin pen needle with the NovoTwist system. The two-step illustration depicts twisting and removing the protective cap from the needle before injection.*

FDA Label Image

Flexpen Ifu C (Image 14)

An instructional illustration showing the connection between an insulin syringe and a Novo Nordisk insulin pen. The diagram depicts how to attach the NovoTwist needle to the pen with directional arrows indicating the steps for use with NovoFine and NovoFine Plus needles.*

FDA Label Image

Flexpen Ifu D (Image 15)

An instructional illustration showing the steps to remove a cap from a Novolin R injection pen. The left panel depicts gripping and pulling off the outer cap, while the right panel shows twisting and removing the inner cap, indicating preparatory actions for subcutaneous injection.*

FDA Label Image

Exclamation Point (Image 16)

Novolin R 100 IU/mL injection solution carton for subcutaneous use by Novo Nordisk. The packaging displays the product name Novolin R and indicates the active ingredient as Human Insulin with a strength of 100 IU/mL. The label includes branding and dosage form information consistent with a human insulin injection solution.*

FDA Label Image

Exclamation Point (Image 17)

Novolin R 100 IU/mL injection, solution in a clear glass vial with a purple cap and purple and white labeling. The label shows branding and dosage information for subcutaneous administration. The product is manufactured by Novo Nordisk.*

FDA Label Image

Exclamation Point (Image 19)

Novolin R 100 IU/mL Injection, Solution for subcutaneous use, packaged in a vial. The label displays Novolin R as the proprietary name and Human Insulin as the generic name. The product is from Novo Nordisk and intended for human OTC drug use.*

FDA Label Image

Select 2 Units. (Image 20)

Instructional illustration showing how to select a dose on an insulin pen. The hand is adjusting the dose selector, which displays '2 units selected' against a dial marked with unit numbers, demonstrating dose adjustment for a subcutaneous insulin injection.*

FDA Label Image

Tap The Cartridge. (Image 21)

An instructional illustration showing a hand holding an insulin syringe. Lines near the syringe indicate a shaking or mixing motion, typically part of preparation for injection.*

FDA Label Image

Keep The Needle Pointing Upwards. (Image 22)

An instructional illustration showing a hand holding an injectable pen device labeled with dose markings and a droplet symbol. The image indicates removing a cap or seal from the pen tip with an upward arrow, highlighting proper preparation before injection.*

FDA Label Image

Exclamation Point (Image 23)

Novolin R Human Insulin 100 IU/mL Injection, Solution in a vial with a blue cap. The label shows the Novo Nordisk logo and indicates the product is for subcutaneous use. Packaging includes barcodes and regulatory markings.*

FDA Label Image

Turn The Dose Selector. (Image 24)

An instructional illustration showing a close-up of a dose selector mechanism on an insulin pen. It highlights selection of 5 units and 24 units, demonstrating how the dose is adjusted by turning the dial on the pen device. The image conveys dose setting steps for subcutaneous injection of Novolin R Human Insulin solution.*

FDA Label Image

Inject The Dose. (Image 25)

An instructional diagram showing a hand holding a Novolin R insulin vial or pen injection device. The illustration depicts the thumb pressing down on the cap or top, with an arrow indicating a downward motion to open or activate the device. A partial close-up of the dosing window or label is also shown.*

FDA Label Image

Keep The Needle In The Skin For At Least 6 Seconds. (Image 26)

An instructional illustration showing the tip of a syringe needle positioned just above the skin surface, indicating preparation for subcutaneous injection.*

FDA Label Image

Put The Pen Cap On. (Image 27)

Illustration showing a hand holding an insulin pen injector, with an arrow indicating the direction to press or push a button on the injector, related to the administration of Novolin R Human Insulin Injection, Solution, 100 IU/mL by subcutaneous route.*

FDA Label Image

Exclamation Point (Image 28)

Novolin R 100 IU/mL injection, solution, subcutaneous use vial label. The clear label includes the brand name Novolin R and active ingredient Human Insulin. It specifies the concentration as 100 IU/mL and indicates it is manufactured by Novo Nordisk.*

FDA Label Image

Exclamation Point (Image 29)

Packaging label of Novolin R 100 [iU]/mL human insulin injection, solution for subcutaneous use. The label includes the Novo Nordisk logo and product details on a white and blue background. It is a vial label for the prescription medication.*

FDA Label Image

Exclamation Point (Image 30)

Novolin R 100 IU/mL injection, solution in a clear vial. The vial label shows the brand name Novolin R and indicates the active ingredient Human Insulin. It is intended for subcutaneous use and is manufactured by Novo Nordisk. The vial contains 10 mL of the insulin solution.*

FDA Label Image

Exclamation Point (Image 31)

Novolin R 100 IU/mL solution for injection vial label by Novo Nordisk. The label displays the proprietary name, concentration in IU/mL, and dosage form as injection solution. The vial is clear with a blue cap and the label includes standard regulatory and product information.*

FDA Label Image

Exclamation Point (Image 32)

Novolin R 100 units/mL injection solution cartridge. The packaging shows a clear glass cartridge with orange cap and label detailing the product name, strength, and manufacturer Novo Nordisk. The cartridge is designed for subcutaneous injection and contains human insulin solution.*

FDA Label Image

Exclamation Point (Image 33)

Novolin R 100 IU/mL injection solution in a vial, labeled for subcutaneous use. The label shows the brand name Novolin R, and identifies human insulin as the active ingredient. The product is manufactured by Novo Nordisk.*

FDA Label Image

Exclamation Point (Image 34)

Novolin R 100 IU/mL injection solution in a vial. The label shows the product name Novolin R and the active ingredient Human Insulin. It is for subcutaneous use and is labeled by Novo Nordisk. The vial has a clear label with text and graphics indicating dosage strength and product information.*

FDA Label Image

Exclamation Point (Image 35)

Novolin R injection, solution 100 IU/mL in a glass vial with a metallic cap, labeled for human insulin use. The vial includes a white label displaying product details, dosage strength, and the Novo Nordisk labeler name. Designed for subcutaneous administration.*

FDA Label Image

Exclamation Point (Image 36)

Novolin R 100 IU/mL injection solution vial with label displaying the proprietary name Novolin R and nonproprietary name Human Insulin. The vial is clear glass with a red top, and the label shows dosing strength of 100 IU/mL. The labeler is Novo Nordisk.*

FDA Label Image

Image Of Novolin R Vial Carton (Image 18)

Packaging label for Novolin R injection, a human insulin solution at 100 units/mL strength. The label includes usage warnings, storage instructions, and contact information for Novo Nordisk, the labeler. It specifies a 10 mL multi-dose vial for subcutaneous use, with branding and regulatory details, including ReliOn and U-100 markings.*

FDA Label Image

Image Of Novolin R Vial Carton (ReliOn)

Novolin R 100 U/mL injection packaging label for human insulin by Novo Nordisk. The label includes instructions for use with U-100 insulin syringes, storage guidelines, and a warning to use under medical supervision. The package is for a 10 mL multi-dose vial and shows the manufacturer as Novo Nordisk A/S, Denmark.*

FDA Label Image

Image Of Novolin R Flexpen Carton (Image 38)

Novolin R FlexPen 100 units/mL (U-100) injection, human insulin solution in 5x 3 mL prefilled pens by Novo Nordisk. Label states for single patient use only, subcutaneous route, with storage conditions and use instructions. Packaging includes Novo Nordisk logos and trademark information.*

FDA Label Image

Image Of Novolin R Flexpen Carton (ReliOn)

Novolin R FlexPen 100 units/mL (U-100) injection, a human insulin solution for subcutaneous use, shown as a carton label. This package contains five 3 mL prefilled pens for single patient use only. Manufactured by Novo Nordisk and includes usage, storage, and safety warnings. The label features the ReliOn brand, specifying retail sale exclusivity to Walmart and its affiliates.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.